These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12039518)

  • 1. The eye's view of antigen presentation.
    Streilein JW; Masli S; Takeuchi M; Kezuka T
    Hum Immunol; 2002 Jun; 63(6):435-43. PubMed ID: 12039518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
    Wilbanks GA; Mammolenti M; Streilein JW
    Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1.
    D'Orazio TJ; Mayhew E; Niederkorn JY
    J Immunol; 2001 Jan; 166(1):26-32. PubMed ID: 11123273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
    Wilbanks GA; Streilein JW
    J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID).
    D'Orazio TJ; Niederkorn JY
    Immunology; 1998 Sep; 95(1):47-55. PubMed ID: 9767456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
    Hara Y; Okamoto S; Rouse B; Streilein JW
    J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune response and the eye. TCR alpha-chain related molecules regulate the systemic immunity to antigen presented in the eye.
    Griffith TS; Herndon JM; Lima J; Kahn M; Ferguson TA
    Int Immunol; 1995 Oct; 7(10):1617-25. PubMed ID: 8562507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
    Farooq SM; Ashour HM
    Brain Behav Immun; 2014 Jan; 35():64-9. PubMed ID: 24095895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
    Niederkorn JY; Mayhew E
    Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aqueous humor factors and their effect on the immune response in the anterior chamber.
    Streilein JW; Cousins SW
    Curr Eye Res; 1990; 9 Suppl():175-82. PubMed ID: 2200643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
    Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.
    Sonoda KH; Exley M; Snapper S; Balk SP; Stein-Streilein J
    J Exp Med; 1999 Nov; 190(9):1215-26. PubMed ID: 10544194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review.
    Streilein JW; Wilbanks GA; Taylor A; Cousins S
    Curr Eye Res; 1992; 11 Suppl():41-7. PubMed ID: 1424750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties.
    Wilbanks GA; Streilein JW
    Reg Immunol; 1992; 4(3):130-7. PubMed ID: 1303096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic restrictions and cellular interactions in the induction of anterior chamber associated immune deviation (ACAID).
    Ferguson TA; Kaplan HJ
    Reg Immunol; 1988; 1(1):62-8. PubMed ID: 2978943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for TGF-beta and IL-10 in the induction of immune privilege.
    D'Orazio TJ; Niederkorn JY
    J Immunol; 1998 Mar; 160(5):2089-98. PubMed ID: 9498745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous recombinant interleukin-2 abrogates anterior-chamber-associated immune deviation.
    Niederkorn JY
    Transplantation; 1987 Apr; 43(4):523-8. PubMed ID: 2953091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation.
    Ashour HM; Niederkorn JY
    J Immunol; 2006 May; 176(10):5950-7. PubMed ID: 16670303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation.
    Streilein JW
    J Leukoc Biol; 2003 Aug; 74(2):179-85. PubMed ID: 12885934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.